Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Telomere length alterations in microsatellite stable colorectal cancer and association with the immune response.

Lopez-Doriga A, Valle L, Alonso MH, Aussó S, Closa A, Sanjuan X, Barquero D, Rodríguez-Moranta F, Sanz-Pamplona R, Moreno V.

Biochim Biophys Acta. 2018 Jun 14. pii: S0925-4439(18)30214-X. doi: 10.1016/j.bbadis.2018.06.010. [Epub ahead of print]

PMID:
29908233
2.

Post-operative morbidity and mortality of a cohort of steroid refractory acute severe ulcerative colitis: Nationwide multicenter study of the GETECCU ENEIDA Registry.

Ordás I, Domènech E, Mañosa M, García-Sánchez V, Iglesias-Flores E, Rodríguez-Moranta F, Márquez L, Merino O, Fernández-Bañares F, Gomollón F, Vera M, Gutiérrez A, LLaó J, Gisbert JP, Aguas M, Arias L, Rodríguez-Lago I, Muñoz C, Alcaide N, Calvet X, Rodríguez C, Montoro MA, García S, De Castro ML, Piqueras M, Pareja L, Ribes J, Panés J, Esteve M; ENEIDA registry of GETECCU.

Am J Gastroenterol. 2018 May 1. doi: 10.1038/s41395-018-0057-0. [Epub ahead of print]

PMID:
29713028
3.

External Evaluation of Population Pharmacokinetic Models of Infliximab in Patients With Inflammatory Bowel Disease.

Santacana E, Rodríguez-Alonso L, Padullés A, Guardiola J, Rodríguez-Moranta F, Serra K, Bas J, Morandeira Biology F, Colom H, Padullés N.

Ther Drug Monit. 2018 Feb;40(1):120-129. doi: 10.1097/FTD.0000000000000476.

PMID:
29200097
4.

Corrigendum: Risk Model for Colorectal Cancer in Spanish Population Using Environmental and Genetic Factors: Results from the MCC-Spain study.

Ibáñez-Sanz G, Díez-Villanueva A, Alonso MH, Rodríguez-Moranta F, Pérez-Gómez B, Bustamante M, Martin V, Llorca J, Amiano P, Ardanaz E, Tardón A, Jiménez-Moleón JJ, Peiró R, Alguacil J, Navarro C, Guinó E, Binefa G, Fernández-Navarro P, Espinosa A, Dávila-Batista V, Molina AJ, Palazuelos C, Castaño-Vinyals G, Aragonés N, Kogevinas M, Pollán M, Moreno V.

Sci Rep. 2017 May 17;7:46807. doi: 10.1038/srep46807. No abstract available.

5.

Increased Risk of Colorectal Cancer in Patients With Multiple Serrated Polyps and Their First-Degree Relatives.

Egoavil C, Juárez M, Guarinos C, Rodríguez-Soler M, Hernández-Illán E, Alenda C, Payá A, Castillejo A, Serradesanferm A, Bujanda L, Fernández-Bañares F, Cubiella J, de-Castro L, Guerra A, Aguirre E, Herreros-de-Tejada A, Bessa X, Herráiz M, Marín-Gabriel JC, Balmaña J, Piñol V, Rodríguez Moranta F, Nicolás-Pérez D, Cuatrecasas M, Balaguer F, Castells A, Soto JL, Zapater P, Jover R.

Gastroenterology. 2017 Jul;153(1):106-112.e2. doi: 10.1053/j.gastro.2017.04.003. Epub 2017 Apr 9.

PMID:
28400194
6.

Risk Model for Colorectal Cancer in Spanish Population Using Environmental and Genetic Factors: Results from the MCC-Spain study.

Ibáñez-Sanz G, Díez-Villanueva A, Alonso MH, Rodríguez-Moranta F, Pérez-Gómez B, Bustamante M, Martin V, Llorca J, Amiano P, Ardanaz E, Tardón A, Jiménez-Moleón JJ, Peiró R, Alguacil J, Navarro C, Guinó E, Binefa G, Fernández-Navarro P, Espinosa A, Dávila-Batista V, Molina AJ, Palazuelos C, Castaño-Vinyals G, Aragonés N, Kogevinas M, Pollán M, Moreno V.

Sci Rep. 2017 Feb 24;7:43263. doi: 10.1038/srep43263. Erratum in: Sci Rep. 2017 May 17;7:46807. Navarro, Pablo Fernández [corrected to Fernández-Navarro, Pablo].

7.

The fecal hemoglobin concentration, age and sex test score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients.

Cubiella J, Digby J, Rodríguez-Alonso L, Vega P, Salve M, Díaz-Ondina M, Strachan JA, Mowat C, McDonald PJ, Carey FA, Godber IM, Younes HB, Rodriguez-Moranta F, Quintero E, Álvarez-Sánchez V, Fernández-Bañares F, Boadas J, Campo R, Bujanda L, Garayoa A, Ferrandez Á, Piñol V, Rodríguez-Alcalde D, Guardiola J, Steele RJ, Fraser CG; COLONPREDICT study investigators.

Int J Cancer. 2017 May 15;140(10):2201-2211. doi: 10.1002/ijc.30639. Epub 2017 Mar 6.

8.

Relationship between drugs affecting the renin-angiotensin system and colorectal cancer: The MCC-Spain study.

Dierssen-Sotos T, Gómez-Acebo I, Palazuelos C, Rodriguez-Moranta F, Pérez-Gómez B, Fernández Vazquez JP, Amiano P, Barricarte A, Mirón-Pozo B, Tardon A, Capelo R, Peiro Pérez R, Huerta JM, Andreu M, Sierra MÁ, Castañón López C, Ruiz I, Moreno-Iribas C, Olmedo-Requena R, Castaño-Vinyals G, Aragonés N, Kogevinas M, Pollán M, Llorca J.

Prev Med. 2017 Jun;99:178-184. doi: 10.1016/j.ypmed.2017.01.011. Epub 2017 Jan 26.

PMID:
28131779
9.

Sectorization of medical and surgical management of inflammatory bowel disease.

Rodríguez-Moranta F, Guardiola J.

Cir Esp. 2016 Dec;94(10):551-552. doi: 10.1016/j.ciresp.2016.11.001. Epub 2016 Nov 22. English, Spanish. No abstract available.

PMID:
27887706
10.

False-negative rate cannot be reduced by lowering the haemoglobin concentration cut-off in colorectal cancer screening using faecal immunochemical test.

Ibañez-Sanz G, Garcia M, Milà N, Rodríguez-Moranta F, Binefa G, Gómez-Matas J, Benito L, Padrol I, Barenys M, Moreno V.

Eur J Cancer Prev. 2017 Sep;26(5):365-367. doi: 10.1097/CEJ.0000000000000281.

PMID:
27433880
11.

Prescription drugs associated with false-positive results when using faecal immunochemical tests for colorectal cancer screening.

Ibáñez-Sanz G, Garcia M, Rodríguez-Moranta F, Binefa G, Gómez-Matas J, Domènech X, Vidal C, Soriano A, Moreno V; ‘Adverse Effects on Colorectal Cancer Screening in Catalonia (EACC) Study’ Working Group.

Dig Liver Dis. 2016 Oct;48(10):1249-54. doi: 10.1016/j.dld.2016.06.011. Epub 2016 Jun 21.

PMID:
27378703
12.

Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000-2012).

Binefa G, Garcia M, Milà N, Fernández E, Rodríguez-Moranta F, Gonzalo N, Benito L, Clopés A, Guardiola J, Moreno V.

Sci Rep. 2016 Jan 20;6:19532. doi: 10.1038/srep19532.

13.

Thiopurine Therapy Reduces the Incidence of Colorectal Neoplasia in Patients with Ulcerative Colitis. Data from the ENEIDA Registry.

Gordillo J, Cabré E, Garcia-Planella E, Ricart E, Ber-Nieto Y, Márquez L, Rodríguez-Moranta F, Ponferrada Á, Vera I, Gisbert JP, Barrio J, Esteve M, Merino O, Muñoz F, Domènech E; ENEIDA Project of the Spanish Working Group in Crohn’s Disease and Ulcerative Colitis (GETECCU).

J Crohns Colitis. 2015 Dec;9(12):1063-70. doi: 10.1093/ecco-jcc/jjv145. Epub 2015 Sep 7.

PMID:
26351379
14.

Colorectal cancer risk factors in patients with serrated polyposis syndrome: a large multicentre study.

Carballal S, Rodríguez-Alcalde D, Moreira L, Hernández L, Rodríguez L, Rodríguez-Moranta F, Gonzalo V, Bujanda L, Bessa X, Poves C, Cubiella J, Castro I, González M, Moya E, Oquiñena S, Clofent J, Quintero E, Esteban P, Piñol V, Fernández FJ, Jover R, Cid L, López-Cerón M, Cuatrecasas M, López-Vicente J, Leoz ML, Rivero-Sánchez L, Castells A, Pellisé M, Balaguer F; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association.

Gut. 2016 Nov;65(11):1829-1837. doi: 10.1136/gutjnl-2015-309647. Epub 2015 Aug 11.

PMID:
26264224
15.

Endoscopic surveillance in patients with multiple (10-100) colorectal polyps.

Valentín F, Guarinos C, Juárez M, Rodríguez-Soler M, Serradesanferm A, Rodriguez-Moranta F, Nicolas-Perez D, Bujanda L, Herraiz M, De-Castro L, Fernández-Bañares F, Herreros-de-Tejada A, Martínez F, Aguirre E, Ferrández Á, Díaz-Tasende J, Piñol V, Paya A, Egoavil C, Alenda C, Castells A, Jover R, Cubiella J.

Endoscopy. 2016 Jan;48(1):56-61. doi: 10.1055/s-0034-1392515. Epub 2015 Jul 10.

PMID:
26165738
16.

An urgent referral strategy for symptomatic patients with suspected colorectal cancer based on a quantitative immunochemical faecal occult blood test.

Rodríguez-Alonso L, Rodríguez-Moranta F, Ruiz-Cerulla A, Lobatón T, Arajol C, Binefa G, Moreno V, Guardiola J.

Dig Liver Dis. 2015 Sep;47(9):797-804. doi: 10.1016/j.dld.2015.05.004. Epub 2015 May 15.

PMID:
26055489
17.

[Approach to the diagnosis and treatment of chronic anemia secondary to gastrointestinal diseases].

Rodríguez-Moranta F, Rodríguez-Alonso L, Guardiola Capón J.

Gastroenterol Hepatol. 2014 Dec;37(10):573-82. Review. Spanish.

PMID:
25443541
18.

Discovery and validation of new potential biomarkers for early detection of colon cancer.

Solé X, Crous-Bou M, Cordero D, Olivares D, Guinó E, Sanz-Pamplona R, Rodriguez-Moranta F, Sanjuan X, de Oca J, Salazar R, Moreno V.

PLoS One. 2014 Sep 12;9(9):e106748. doi: 10.1371/journal.pone.0106748. eCollection 2014.

19.

Relationship between methylation and colonic inflammation in inflammatory bowel disease.

Lobatón T, Azuara D, Rodríguez-Moranta F, Loayza C, Sanjuan X, de Oca J, Fernández-Robles A, Guardiola J, Capellá G.

World J Gastroenterol. 2014 Aug 14;20(30):10591-8. doi: 10.3748/wjg.v20.i30.10591.

20.

Fecal level of calprotectin identifies histologic inflammation in patients with ulcerative colitis in clinical and endoscopic remission.

Guardiola J, Lobatón T, Rodríguez-Alonso L, Ruiz-Cerulla A, Arajol C, Loayza C, Sanjuan X, Sánchez E, Rodríguez-Moranta F.

Clin Gastroenterol Hepatol. 2014 Nov;12(11):1865-70. doi: 10.1016/j.cgh.2014.06.020. Epub 2014 Jun 30.

PMID:
24993368
21.

Serrated polyposis syndrome.

Rodriguez-Moranta F, Rodriguez-Alonso L, Guardiola Capon J.

Cir Esp. 2014 Dec;92(10):643-4. doi: 10.1016/j.ciresp.2014.03.003. Epub 2014 Jun 18. English, Spanish. No abstract available.

PMID:
24952723
22.

Colorectal cancer: from prevention to personalized medicine.

Binefa G, Rodríguez-Moranta F, Teule A, Medina-Hayas M.

World J Gastroenterol. 2014 Jun 14;20(22):6786-808. doi: 10.3748/wjg.v20.i22.6786. Review.

23.

Risk of colectomy in patients with ulcerative colitis under thiopurine treatment.

Cañas-Ventura A, Márquez L, Ricart E, Domènech E, Gisbert JP, García-Sanchez V, Marín-Jiménez I, Rodriguez-Moranta F, Gomollón F, Calvet X, Merino O, Garcia-Planella E, Vázquez-Romero N, Esteve M, Iborra M, Gutiérrez A, Vera M, Andreu M; Spanish GETECCU group (ENEIDA project).

J Crohns Colitis. 2014 Oct;8(10):1287-93. doi: 10.1016/j.crohns.2014.03.014. Epub 2014 Apr 13.

PMID:
24726696
24.

Aberrant gene expression in mucosa adjacent to tumor reveals a molecular crosstalk in colon cancer.

Sanz-Pamplona R, Berenguer A, Cordero D, Molleví DG, Crous-Bou M, Sole X, Paré-Brunet L, Guino E, Salazar R, Santos C, de Oca J, Sanjuan X, Rodriguez-Moranta F, Moreno V.

Mol Cancer. 2014 Mar 5;13:46. doi: 10.1186/1476-4598-13-46.

25.

Prevalence and characteristics of MUTYH-associated polyposis in patients with multiple adenomatous and serrated polyps.

Guarinos C, Juárez M, Egoavil C, Rodríguez-Soler M, Pérez-Carbonell L, Salas R, Cubiella J, Rodríguez-Moranta F, de-Castro L, Bujanda L, Serradesanferm A, Nicolás-Pérez D, Herráiz M, Fernández-Bañares F, Herreros-de-Tejada A, Aguirre E, Balmaña J, Rincón ML, Pizarro A, Polo-Ortiz F, Castillejo A, Alenda C, Payá A, Soto JL, Jover R.

Clin Cancer Res. 2014 Mar 1;20(5):1158-68. doi: 10.1158/1078-0432.CCR-13-1490. Epub 2014 Jan 27.

26.

Colonoscopy quality assessment in a mass population screening programme based on faecal occult blood test.

Binefa G, García M, Milà N, Rodríguez L, Rodríguez-Moranta F, Guardiola J, Moreno V.

Rev Esp Enferm Dig. 2013 Aug;105(7):400-8.

27.

Comparison of the long-term outcome of two therapeutic strategies for the management of abdominal abscess complicating Crohn's disease: percutaneous drainage or immediate surgical treatment.

Lobatón T, Guardiola J, Rodriguez-Moranta F, Millán-Scheiding M, Peñalva M, De Oca J, Biondo S.

Colorectal Dis. 2013;15(10):1267-72. doi: 10.1111/codi.12419.

PMID:
24102970
28.

Reply to Dr. Papamichael et al.'s letter.

Lobatón T, Rodríguez-Moranta F, Guardiola J.

J Crohns Colitis. 2013 Dec;7(12):e702-3. doi: 10.1016/j.crohns.2013.08.011. Epub 2013 Sep 9. No abstract available.

PMID:
24029443
29.

A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease.

Lobatón T, López-García A, Rodríguez-Moranta F, Ruiz A, Rodríguez L, Guardiola J.

J Crohns Colitis. 2013 Dec;7(12):e641-51. doi: 10.1016/j.crohns.2013.05.005. Epub 2013 Jul 1.

PMID:
23810085
30.

[Management of acute lower gastrointestinal hemorrhage: position statement of the Catalan Society of Gastroenterology].

Guardiola J, García-Iglesias P, Rodríguez-Moranta F, Brullet E, Salo J, Alba E, Espin E, Gallach M, Gené E, Titó L, Feu F, Villanueva C, Fort E, Martínez-Cerezo FJ, Planella M, Pons V, Calvet X; Societat Catalana de Medicina d’Urgències i Emergències; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III.

Gastroenterol Hepatol. 2013 Oct;36(8):534-45. doi: 10.1016/j.gastrohep.2013.04.002. Epub 2013 Jun 20. Spanish. No abstract available.

PMID:
23790810
31.

DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer.

Carmona FJ, Azuara D, Berenguer-Llergo A, Fernández AF, Biondo S, de Oca J, Rodriguez-Moranta F, Salazar R, Villanueva A, Fraga MF, Guardiola J, Capellá G, Esteller M, Moreno V.

Cancer Prev Res (Phila). 2013 Jul;6(7):656-65. doi: 10.1158/1940-6207.CAPR-12-0501. Epub 2013 May 21.

32.

A new rapid quantitative test for fecal calprotectin predicts endoscopic activity in ulcerative colitis.

Lobatón T, Rodríguez-Moranta F, Lopez A, Sánchez E, Rodríguez-Alonso L, Guardiola J.

Inflamm Bowel Dis. 2013 Apr;19(5):1034-42. doi: 10.1097/MIB.0b013e3182802b6e.

PMID:
23470502
33.

[Fecal calprotectin in the diagnosis of inflammatory bowel diseases].

Rodríguez-Moranta F, Lobatón T, Rodríguez-Alonso L, Guardiola J.

Gastroenterol Hepatol. 2013 Jun-Jul;36(6):400-6. doi: 10.1016/j.gastrohep.2012.10.008. Epub 2013 Feb 19. Spanish.

PMID:
23434080
34.

[Current status of elective surgical treatment of ulcerative colitis. A systematic review].

Millán Scheiding M, Rodriguez Moranta F, Kreisler Moreno E, Golda T, Fraccalvieri D, Biondo S.

Cir Esp. 2012 Nov;90(9):548-57. doi: 10.1016/j.ciresp.2012.07.019. Epub 2012 Oct 9. Review. Spanish.

PMID:
23063060
35.

[Hyperplastic polyposis syndrome: phenotypic diversity and association to colorectal cancer].

Navarro M, González S, Iglesias S, Capellá G, Rodríguez-Moranta F, Blanco I.

Med Clin (Barc). 2013 Jul 21;141(2):62-6. doi: 10.1016/j.medcli.2012.04.024. Epub 2012 Jul 17. Spanish.

PMID:
22809968
36.

Nanofluidic digital PCR for KRAS mutation detection and quantification in gastrointestinal cancer.

Azuara D, Ginesta MM, Gausachs M, Rodriguez-Moranta F, Fabregat J, Busquets J, Pelaez N, Boadas J, Galter S, Moreno V, Costa J, de Oca J, Capellá G.

Clin Chem. 2012 Sep;58(9):1332-41. doi: 10.1373/clinchem.2012.186577. Epub 2012 Jun 27.

37.

Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn's colitis patients.

Azuara D, Rodriguez-Moranta F, de Oca J, Sanjuan X, Guardiola J, Lobaton T, Wang A, Boadas J, Piqueras M, Monfort D, Galter S, Esteller M, Moreno V, Capellá G.

Inflamm Bowel Dis. 2013 Jan;19(1):165-73. doi: 10.1002/ibd.22994.

PMID:
22532293
38.

Impact of age on recurrence and severity of left colonic diverticulitis.

Lopez-Borao J, Kreisler E, Millan M, Trenti L, Jaurrieta E, Rodriguez-Moranta F, Miguel B, Biondo S.

Colorectal Dis. 2012 Jul;14(7):e407-12. doi: 10.1111/j.1463-1318.2012.02976.x.

PMID:
22321968
39.

Genetic polymorphisms in fatty acid metabolism genes and colorectal cancer.

Crous-Bou M, Rennert G, Salazar R, Rodriguez-Moranta F, Rennert HS, Lejbkowicz F, Kopelovich L, Lipkin SM, Gruber SB, Moreno V.

Mutagenesis. 2012 Mar;27(2):169-76. doi: 10.1093/mutage/ger066.

40.

[Evaluating colorectal cancer screening strategies (immunological test vs biochemical test) in Catalonia, Spain 2008-2010].

García Martínez M, Binefa Rodríguez G, Milà Díaz N, Rodríguez Moranta F, Gonzalo Diego N, Muñoz Sánchez C, Espinàs Piñol JA, Borràs Andrés JM, Moreno Aguado V.

Rev Esp Salud Publica. 2011 Dec;85(6):593-602. doi: 10.1590/S1135-57272011120000008. Spanish.

41.

[Diagnostic performance of colonoscopy in lower gastrointestinal bleeding].

Rodriguez Moranta F, Berrozpe A, Guardiola J.

Gastroenterol Hepatol. 2011 Oct;34(8):551-7. doi: 10.1016/j.gastrohep.2011.06.003. Epub 2011 Aug 31. Review. Spanish.

PMID:
21885162
42.

Endoscopic retrieval of a surgical gauze from the right colon.

Gornals-Soler JB, Lobatón-Ortega T, Rodríguez-Moranta F, Miquel-Collell J.

Rev Esp Enferm Dig. 2010 Nov;102(11):658-9. No abstract available.

43.

Novel methylation panel for the early detection of colorectal tumors in stool DNA.

Azuara D, Rodriguez-Moranta F, de Oca J, Soriano-Izquierdo A, Mora J, Guardiola J, Biondo S, Blanco I, Peinado MA, Moreno V, Esteller M, Capellá G.

Clin Colorectal Cancer. 2010 Jul;9(3):168-76. doi: 10.3816/CCC.2010.n.023.

PMID:
20643622
44.

Telomerase mRNA expression and immunohistochemical detection as a biomarker of malignant transformation in patients with inflammatory bowel disease.

Gonzalo V, Petit A, Castellví-Bel S, Pellisé M, Muñoz J, Piñol C, Rodríguez-Moranta F, Clofent J, Balaguer F, Giráldez MD, Ocaña T, Serradesanferm A, Grau J, Reñé JM, Panés J, Castells A.

Gastroenterol Hepatol. 2010 Apr;33(4):288-96. doi: 10.1016/j.gastrohep.2009.12.011. Epub 2010 Mar 23.

PMID:
20334955
45.

Colorectal cancer screening: strategies to select populations with moderate risk for disease.

Navarro M, Binefa G, Blanco I, Guardiola J, Rodríguez-Moranta F, Peris M; Catalan Colorectal Cancer Screening Pilot Programme Group.

Rev Esp Enferm Dig. 2009 Dec;101(12):855-60.

46.

Endoscopic requirements of colorectal cancer screening programs in average-risk population. Estimation according to a Markov model.

Rodríguez-Moranta F, Trapero-Bertran M, Castells A, Mas-Canal X, Balaguer F, Pellisé M, Gonzalo V, Ocaña T, Trilla A, Piqué JM.

Gastroenterol Hepatol. 2008 Aug-Sep;31(7):405-12.

PMID:
18783684
47.

[Current status of treatment of inflammatory bowel disease].

Rodríguez-Moranta F, Soriano-Izquierdo A, Guardiola J.

Cir Esp. 2007 Nov;82(5):254-9. Review. Spanish.

48.

[Long-term results of emergency surgery for colon cancer compared with elective surgery].

Biondo S, Kreisler E, Millan M, Martí-Ragué J, Fraccalvieri D, Golda T, De Oca J, Osorio A, Fradera R, Salazar R, Rodriguez-Moranta F, Sanjuán X.

Cir Esp. 2007 Aug;82(2):89-98. Spanish.

49.

Clinical performance of original and revised Bethesda guidelines for the identification of MSH2/MLH1 gene carriers in patients with newly diagnosed colorectal cancer: proposal of a new and simpler set of recommendations.

Rodríguez-Moranta F, Castells A, Andreu M, Piñol V, Castellví-Bel S, Alenda C, Llor X, Xicola RM, Jover R, Payá A, Bessa X, Balaguer F, Cubiella J, Argüello L, Morillas JD, Bujanda L; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association.

Am J Gastroenterol. 2006 May;101(5):1104-11.

PMID:
16696788
50.

Cyclooxygenase 2 expression in colorectal cancer with DNA mismatch repair deficiency.

Castells A, Payá A, Alenda C, Rodríguez-Moranta F, Agrelo R, Andreu M, Piñol V, Castellví-Bel S, Jover R, Llor X, Pons E, Elizalde JI, Bessa X, Alcedo J, Saló J, Medina E, Naranjo A, Esteller M, Piqué JM; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association.

Clin Cancer Res. 2006 Mar 15;12(6):1686-92.

Supplemental Content

Loading ...
Support Center